Glutamate, excitotoxicity and amyotrophic lateral sclerosis

Journal of Neurology
P J Shaw, P G Ince

Abstract

The "glutamate hypothesis" is one of three major pathophysiological mechanisms of motor neurone injury towards which current research effort into amyotrophic lateral sclerosis (ALS) is directed. There is great structural and functional diversity in the glutamate receptor family which results from combinations of 14 known gene products and their splice variants, with or without additional RNA editing. It is possible that motor neurones express a unique molecular profile of glutamate receptors. Abnormal activation of glutamate receptors is one of five main candidates as a final common pathway to neuronal death. In classical acute excitotoxicity, there is influx of Na+ and CI-, and destabilisation of intracellular Ca2+ homeostasis, which activates a cascade of harmful biochemical events. The concept of secondary excitotoxicity, where cellular injury by glutamate is triggered by disturbances in neuronal energy status, may be particularly relevant to a chronic neurodegenerative disease such as ALS. Data are now beginning to emerge on the fine molecular structure of the glutamate receptors present on human motor neurones, which have a distinct profile of AMPA receptors. Two important molecular features of motor neurones have been ide...Continue Reading

References

Jul 1, 1979·Annals of Neurology·H M Kurlander, B M Patten
Dec 1, 1977·Neurology·M StrieflerE Schujman
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T StorckW Stoffel
Dec 10, 1992·The New England Journal of Medicine·R G SmithS H Appel
May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 2, 1992·Nature·T KutsuwadaM Arakawa
Jul 1, 1992·Trends in Pharmacological Sciences·B Sommer, P H Seeburg
Nov 1, 1992·Journal of Neurochemistry·B Halliwell
Oct 1, 1992·Current Opinion in Neurobiology·M F Beal
Mar 23, 1992·FEBS Letters·M YamazakiM Mishina
Feb 1, 1992·Journal of the Neurological Sciences·Y IwasakiM Kinoshita
Dec 1, 1991·Pflügers Archiv : European journal of physiology·E Benoit, D Escande
Dec 1, 1991·Annals of Neurology·G R StewartW D Snider
Jun 21, 1990·The New England Journal of Medicine·T M PerlR S Remis
Jun 21, 1990·The New England Journal of Medicine·J S TeitelbaumN R Cashman
Aug 3, 1990·Science·K KeinänenP H Seeburg
Sep 1, 1990·Trends in Pharmacological Sciences·B Meldrum, J Garthwaite
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Jan 1, 1988·Annals of the New York Academy of Sciences·B K Siesjö
Jan 1, 1989·Journal of Neural Transmission. General Section·J DunlopR Griffiths
Nov 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M P MattsonS B Kater
Jan 1, 1989·Annals of the New York Academy of Sciences·R J MillerS R Glaum
Nov 8, 1986·Lancet·P S SpencerH H Schaumburg

❮ Previous
Next ❯

Citations

Nov 25, 2000·Journal of the Neurological Sciences·O Hurko, F S Walsh
Oct 26, 2001·Journal of the Neurological Sciences·J Karitzky, A C Ludolph
Dec 16, 1998·Journal of the Neurological Sciences·R K PhulP G Ince
Aug 17, 1999·Journal of the Neurological Sciences·S KalraN R Cashman
Oct 16, 1999·Journal of the Neurological Sciences·S OnoK Nagao
Dec 3, 1999·Journal of the Neurological Sciences·H AsaharaJ Kira
Jul 16, 2002·Pharmacology, Biochemistry, and Behavior·Alessandra ValerioPierFranco Spano
Feb 5, 1998·Brain Research. Molecular Brain Research·I D MiltonP J Shaw
Feb 19, 2002·Neurochemistry International·Fiona M MenziesPamela J Shaw
Oct 16, 2002·Neuroscience Letters·Jean-Pierre Ternaux, Paule Portalier
Jan 12, 1999·British Journal of Pharmacology·J P HubertA Doble
Jun 2, 2001·The New England Journal of Medicine·L P Rowland, N A Shneider
Jun 28, 2003·Neurotoxicity Research·Wojciech Danysz, Chris G Parsons
Jul 23, 1999·Acta Neurologica Scandinavica·I Niebroj-Dobosz, P Janik
Apr 24, 1999·BMJ : British Medical Journal·P J Shaw
Mar 28, 2013·Oxidative Medicine and Cellular Longevity·Sonam ParakhJulie D Atkin
Mar 28, 2013·Mediators of Inflammation·Guan-Ting LiuHao-Teng Chang
Nov 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chen LaiHuaibin Cai
Sep 7, 2006·Experimental Brain Research·Patricia Souza dos SantosPaulo Cesar de Carvalho-Alves
Nov 13, 2004·Neuroreport·Alida SpalloniPatrizia Longone
Mar 20, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Aleksandar IgnjatovićIvan Spasojević
May 5, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Anna WuolikainenPeter M Andersen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.